OFI Invest Asset Management Boosts Holdings in Kenvue Inc. $KVUE

OFI Invest Asset Management boosted its position in Kenvue Inc. (NYSE:KVUE) by 705.6% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 26,979 shares of the company’s stock after buying an additional 23,630 shares during the period. OFI Invest Asset Management’s holdings in Kenvue were worth $565,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently bought and sold shares of KVUE. Pittenger & Anderson Inc. purchased a new position in Kenvue in the 1st quarter valued at $30,000. Trust Co. of Vermont boosted its stake in shares of Kenvue by 266.8% in the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after buying an additional 1,150 shares in the last quarter. TruNorth Capital Management LLC purchased a new stake in shares of Kenvue in the first quarter valued at approximately $36,000. Truvestments Capital LLC purchased a new stake in shares of Kenvue in the first quarter valued at approximately $37,000. Finally, Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Kenvue by 378.5% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,627 shares of the company’s stock valued at $39,000 after buying an additional 1,287 shares in the last quarter. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on KVUE. Citigroup decreased their price target on Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday. Bank of America decreased their price target on Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Rothschild & Co Redburn upgraded Kenvue from a “neutral” rating to a “buy” rating and decreased their price target for the company from $22.50 to $22.00 in a research note on Friday, September 26th. Zacks Research upgraded Kenvue to a “strong sell” rating in a research note on Monday, August 11th. Finally, UBS Group decreased their price target on Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus price target of $21.18.

Kenvue Stock Down 1.0%

KVUE opened at $16.68 on Monday. The business’s fifty day moving average is $19.15 and its two-hundred day moving average is $21.31. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98. The company has a market cap of $32.00 billion, a price-to-earnings ratio of 22.53, a PEG ratio of 2.39 and a beta of 0.72. Kenvue Inc. has a one year low of $15.47 and a one year high of $25.17.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were issued a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.0%. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue’s payout ratio is presently 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.